[Medical management of inflammatory bowel disease: consensus and controversies].
Bouhnik
Yoram
Y
Hépato-Gastroentérologie et Assistance nutritive, Hôpital Lariboisière, 2, rue Ambroise-Paré, 75475 Paris Cedex 10. yoram.bouhnik@lrb.ap-hop-paris.fr
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000175:diagnosis* / Q000628:therapy*; D003424:Crohn Disease / Q000628:therapy*; D016572:Cyclosporine / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D010288:Parenteral Nutrition; D011300:Preoperative Care
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000069285:Infliximab
Prise en charge médicale des MICI: les consensus et les controverses.